The ability of the anti-Wnt-1 antibody to down-regulate the expression of downstream targets of Wnt/β-catenin signaling, including c-Myc, cyclin D1, and survivin, suggest that a broad spectrum of cellular mechanisms can be triggered in concert to halt HCC tumor growth. Here, CCND1 is linked to neoplasm.